Intact thrombin generation and decreased fibrinolytic capacity in patients with acute liver injury or acute liver failure

Journal of Thrombosis and Haemostasis

Volumn 10, Issue 7, 2012, Pages 1312-1319

  Lisman, T ^a   Bakhtiari, K ^b   Adelmeijer, J ^a   Meijers, J C M ^b   Porte, R J ^a   Stravitz, R T ^c  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Acetaminophen; Acute liver failure; Acute liver injury; Coagulation; Fibrinolysis; Thrombin

Indexed keywords

ALANINE AMINOTRANSFERASE; AMMONIA; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; HEMOGLOBIN; LACTIC ACID; PHOSPHATE; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBIN; THROMBOMODULIN;

ACUTE LIVER FAILURE; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMMONIA BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLEEDING; BODY TEMPERATURE; BREATHING RATE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEATH; FEMALE; FIBRINOLYSIS; HEAT STROKE; HEMOGLOBIN BLOOD LEVEL; HEPATIC ENCEPHALOPATHY; HOSPITAL ADMISSION; HUMAN; INFECTION; INTERNATIONAL NORMALIZED RATIO; INTRACRANIAL HYPERTENSION; ISCHEMIA; KIDNEY FAILURE; LACTATE BLOOD LEVEL; LEUKOCYTE COUNT; LIVER INJURY; LIVER TRANSPLANTATION; MALE; MEAN ARTERIAL PRESSURE; NEOPLASM; PARTIAL THROMBOPLASTIN TIME; PH; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PULSE RATE; THROMBOCYTE COUNT; THROMBOSIS;

ADULT; FEMALE; FIBRINOLYSIS; HEMOSTASIS; HUMANS; LIVER; LIVER FAILURE, ACUTE; MALE; MIDDLE AGED; THROMBIN;

EID: 84863454414     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2012.04770.x     Document Type: Article

References (26)

1. Lisman T, Leebeek FW, De Groot PG. Haemostatic abnormalities in patients with liver disease. J Hepatol 2002; 37: 280-7.
2. Lisman T, Porte RJ. Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences. Blood 2010; 116: 878-85.
3. Tripodi A, Salerno F, Chantarangkul V, Clerici M, Cazzaniga M, Primignani M, Mannuccio Mannucci P. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology 2005; 41: 553-8.
4. Gatt A, Riddell A, Calvaruso V, Tuddenham EG, Makris M, Burroughs AK. Enhanced thrombin generation in patients with cirrhosis-induced coagulopathy. J Thromb Haemost 2010; 8: 1994-2000.
5. Lisman T, Leebeek FW, Mosnier LO, Bouma BN, Meijers JC, Janssen HL, Nieuwenhuis HK, De Groot PG. Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis. Gastroenterology 2001; 121: 131-9.
6. Colucci M, Binetti BM, Branca MG, Clerici C, Morelli A, Semeraro N, Gresele P. Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis. Hepatology 2003; 38: 230-7.
7. Stravitz RT, Kramer DJ. Management of acute liver failure. Nat Rev Gastroenterol Hepatol 2009; 6: 542-53.
8. Lisman T, Porte RJ. Activation and regulation of hemostasis in acute liver failure and acute pancreatitis. Semin Thromb Hemost 2010; 36: 437-43.
9. Munoz SJ, Stravitz RT, Gabriel DA. Coagulopathy of acute liver failure. Clin Liver Dis 2009; 13: 95-107.
10. Munoz SJ, Rajender Reddy K, Lee W, Acute Liver Failure Study Group. The coagulopathy of acute liver failure and implications for intracranial pressure monitoring. Neurocrit Care 2008; 9: 103-7.
11. Stravitz RT, Lisman T, Luketic VA, Sterling RK, Puri P, Fuchs M, Ibrahim A, Lee WM, Sanyal AJ. Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by thromboelastography. J Hepatol 2012; 56: 129-36.
12. Lisman T, Bakhtiari K, Pereboom IT, Hendriks HG, Meijers JC, Porte RJ. Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests. J Hepatol 2010; 52: 355-61.
13. Meltzer ME, Lisman T, Doggen CJ, De Groot PG, Rosendaal FR. Synergistic effects of hypofibrinolysis and genetic and acquired risk factors on the risk of a first venous thrombosis. PLoS Med 2008; 5: e97.
14. Mosnier LO, Von dem Borne PA, Meijers JC, Bouma BN. Plasma TAFI levels influence the clot lysis time in healthy individuals in the presence of an intact intrinsic pathway of coagulation. Thromb Haemost 1998; 80: 829-35.
15. Meltzer ME, Lisman T, De Groot PG, Meijers JC, Le Cessie S, Doggen CJ, Rosendaal FR. Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1. Blood 2010; 116: 113-21.
16. Torbet J. The thrombin activation pathway modulates the assembly, structure and lysis of human plasma clots in vitro. Thromb Haemost 1995; 73: 785-92.
17. Wolberg AS, Campbell RA. Thrombin generation, fibrin clot formation and hemostasis. Transfus Apher Sci 2008; 38: 15-23.
18. Hillenbrand P, Parbhoo SP, Jedrychowski A, Sherlock S. Significance of intravascular coagulation and fibrinolysis in acute hepatic failure. Gut 1974; 15: 83-8.
19. Ganey PE, Luyendyk JP, Newport SW, Eagle TM, Maddox JF, Mackman N, Roth RA. Role of the coagulation system in acetaminophen-induced hepatotoxicity in mice. Hepatology 2007; 46: 1177-86.
20. Weerasinghe SV, Moons DS, Altshuler PJ, Shah YM, Omary MB. Fibrinogen-gamma proteolysis and solubility dynamics during apoptotic mouse liver injury: heparin prevents and treats liver damage. Hepatology 2011; 53: 1323-32.
21. Meltzer ME, Doggen CJ, De Groot PG, Rosendaal FR, Lisman T. Plasma levels of fibrinolytic proteins and the risk of myocardial infarction in men. Blood 2010; 116: 529-36.
22. Guimaraes AH, De Bruijne EL, Lisman T, Dippel DW, Deckers JW, Poldermans D, Rijken DC, Leebeek FW. Hypofibrinolysis is a risk factor for arterial thrombosis at young age. Br J Haematol 2009; 145: 115-20.
23. Shami VM, Caldwell SH, Hespenheide EE, Arseneau KO, Bickston SJ, Macik BG. Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy. Liver Transpl 2003; 9: 138-43.
24. Benson AB, Austin GL, Berg M, McFann KK, Thomas S, Ramirez G, Rosen H, Silliman CC, Moss M. Transfusion-related acute lung injury in ICU patients admitted with gastrointestinal bleeding. Intensive Care Med 2010; 36: 1710-7.
25. Thabut D, Rudler M, Rousseau G, Poynard T. Recombinant activated factor VII in chronic liver diseases: should we be afraid of thromboembolic events? J Hepatol 2011; 55: 483-5.
26. Pavese P, Bonadona A, Beaubien J, Labrecque P, Pernod G, Letoublon C, Barnoud D. FVIIa corrects the coagulopathy of fulminant hepatic failure but may be associated with thrombosis: a report of four cases. Can J Anaesth 2005; 52: 26-9.